Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: Effects on fat distribution, insulin sensitivity and lipid metabolism

Aging Male

Volumn 6, Issue 3, 2003, Pages 151-156

  Jedrzejuk, D ^a   Medras, M ^a   Milewicz, A ^a   Demissie, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Aging; DHEA; Men

Indexed keywords

CHOLESTEROL; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE; PRASTERONE SULFATE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADRENARCHE; ADULT; AGING; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0242551105     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.1080/tam.6.3.151.156     Document Type: Article

References (25)

1. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab 1996;9:3147-51
2. Nestler JE. Dehydroepiandrosterone: fountain of youth or snake oil? Endocrinologist 1977;7:423-8
3. Vermeulen A. Physiopathology of dehydroepiandrosterone and its sulfate. In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing, 1999:13-34
4. Baulieu EE. Neuroactive neurosteroids: dehydroepiandrosterone and dehydroepiandrosterone sulfate. In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing, 1999:35-68
5. Labrie F, Belanger A, Luu-The V, Simard J, Lin SX, Cusan L, Labrie C. Role DHEA transformation into androgens and estrogens in peripheral interactive tissues In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing, 1999:69-104
6. Pashiko L, Schwarts AG. Antihyperglycemic effect of dehydroepiandrosterone analogue 16 alpha-fluoro-5-androsten-17-one in diabetic mice. Diabetes 1996;42:1105-8
7. Svec F, Hilton CW, Qright BE. The effect of DHEA given chronically to Zucker rats. Proc Soc Exp Biol Med 1995;209:92-7
8. Bednarek-Tupikowska G, Milewicz A, Kossowska B, Bohdanowicz-Pawlak A, Sciborski R. The influence of DHEA on serum lipids, insulin and sex hormone levels in rabbits with induced hypercholesterolemia. Gynecol Endocrinol 1995;9:23-8
9. Arlt W, Callies F, van Vlijmen J. Dehydroepiandrosterone replacement in women with hypopituitarism. N Engl J Med 1999;341:1013-20
10. Hunt P, Gurnell E, Huppert F. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000;85:4650-6
11. Milewicz A, Jȩdrzejuk D, Bohdanowicz-Pawlak A, Lwow F. The influence of DHEA treatment on bone turnover parameters and bone mineral density in postmenopausal women. In Genazzani A, ed. Proceedings of the European Society for Gynecologic and Obstetric Investigation. Rome: CIC Edizioni Internazionali, 2002:416-20
12. Svec F, Porter J. Dehydroepiandrosterone in metabolic diseases. In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing, 1999:105-26
13. Arlt W, Callies F, Koehler I, van Vlijmen JCh, Fassnacht M, Strasburger ChJ, et al. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab 2001;6:4686-92
14. Legrain S, Massien Ch, Lahlou N, Roger M, Debuire B, Diquet B, et al. Dehydroepiandrosterone administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 2000;85:3208-17
15. Barrett-Connor E, Khaw KT, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N Engl J Med 1996;315:1519-24
16. Nestler JE, Barlancini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1998;66:57-61
17. Morales AJ, Lolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advanced age. J Clin Endocrinol Metab 1994;78:1360-7
18. Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women potential remedial effects. Ann NY Sci 1995;443:128-42
19. Williams MR, Ling S, Dawood T, Hashimura K, Dai A, Li HE, et al. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ars and ers. J Clin Endocrinol Metab 2000;87:176-81
20. Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to G alpha(i2,3). J Biol Chem 2002;14:21379-88
21. Aleksandersen P, Haarabo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996;125:1-13
22. Simon D, Charles MA, Nahoul K, Orssaud G, Kremski J, Hully V, et al. Between plasma testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study. J Clin Endocrinol Metab 1997;82:682-5
23. Coleman DL. Therapeutic effects of dehydroepiandrosterone treatment in rats with diet-induced obesity. Prog Clin Biol Res 1988;265:161-75
24. Buffingtom CK, Pourmotabbed G, Kitabchi AE. Case report: amelioration of insulin resistance in diabetes with dehydroepiandrosterone. Am J Med Sci 2000;306:320-4
25. Herrington DMN, Gordon GB, Aschuff SC. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 1990;16:862-70